Ezio Bonvini - 22 Feb 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn M. Cilinski, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
22 Feb 2024
Net transactions value
-$160,252
Form type
4
Filing time
26 Feb 2024, 16:26:26 UTC
Previous filing
20 Feb 2024
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +28,125 +34% $0.000000 110,258 22 Feb 2024 Direct F1
transaction MGNX Common Stock Tax liability $160,252 -9,366 -8.5% $17.11 100,892 22 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -28,125 -100% $0.000000* 0 22 Feb 2024 Common Stock 28,125 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.